TXMD - TherapeuticsMD, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

TXMD is currently covered by 3 analysts with average potential upside of $244.92 (101.75%) backed by 58 price targets and 68 ratings. Documented since 01-Nov-2013. Analyst's average stock valuation to be materialised ratio is 22.18% with an average time for price targets to be met of 103 days.

Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 11-Jan-2023.

Highest price target for TXMD is 47, Lowest price target is 3, average price target is 25.

Currently, out of the existing stock ratings of TXMD - 2 which are a Buy (40%), 3 which are a Hold (60%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

5

$1.28 (34.41%)

1

2 months 17 days ago

1/3 (33.33%)

$-2.07 (-49.16%)

29

Buy

10

$6.28 (168.82%)

9 months 21 days ago

1/2 (50%)

$81.54 (43.94%)

28

Buy

250

$246.28 (6620.43%)

450

1 years 7 months 23 days ago

0/6 (0%)

$402.73 (227.33%)

Sell

150

2 years 7 months 21 days ago

2/3 (66.67%)

$161 (41.64%)

83

Buy

2 years 11 months 12 days ago

1/19 (5.26%)

$616.84 (272.28%)

581

Show more analysts

What is TXMD(TherapeuticsMD, Inc) average time for price targets to be met?

On average it took 103 days on average for the stock forecasts to be realized with a an average price target met ratio 22.18

Which analyst has the current highest performing score on TXMD(TherapeuticsMD, Inc) with a proven track record?

CHRIS HOWERTON